GMP Inspection and Audit Readiness
What It Is: Regulatory agencies conduct GMP inspections of pharmaceutical manufacturing facilities to verify that products are consistently manufactured and controlled according to quality standards. An unannounced or pre-approval inspection that reveals deficiencies can halt product approvals or result in enforcement action.
ReguLinx provides GMP audit preparation and readiness support — reviewing your quality systems, identifying vulnerabilities, and helping you prepare robust responses to inspection observations. We bring direct GMP compliance expertise to help manufacturing sites achieve and maintain regulatory compliance.
Key Benefits:
- Independent assessment of GMP readiness
- Expert review of SOPs, batch records, and quality systems
- Preparation of CAPA responses and corrective action plans
- Support for US FDA, EMA, PMDA, and ANVISA GMP inspections
Document Review and Quality Compliance
ReguLinx experts review GMP documents including analytical method validation protocols and reports, batch manufacturing records (BMRs), manufacturing process validation protocols and reports, and stability study protocols — ensuring these documents meet regulatory and quality standards before submission or inspection.
Warehouse, Distribution, and Storage Compliance
For pharmaceutical products, compliant storage, distribution, and warehousing practices are regulatory requirements. We provide regulatory and quality compliance guidance for pharmaceutical warehousing and distribution operations — supporting clients in meeting GDP (Good Distribution Practice) requirements across global markets.